featured
Tool Integrating the 21-Gene Recurrence Score and Clinical–Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
J. Clin. Oncol 2020 Dec 11;[EPub Ahead of Print], JA Sparano, MR Crager, G Tang, RJ Gray, SM Stemmer, S ShakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.